![]() Albany Times Union | Pfizer shares at risk following heart-drug failure Reuters - By Ransdell Pierson. NEW YORK (Reuters) - With the sudden failure of torcetrapib Pfizer Inc.'s most important experimental product financial analysts predict shares of the world's largest drugmaker could ... Health Highlights: Dec. 3 2006 Pfizer under pressure to cut costs |